Cargando…
IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis
BACKGROUND: The possibility to better predict the severity of the disease in a patient newly diagnosed with multiple sclerosis would allow the treatment strategy to be personalized and lead to better clinical outcomes. Prognostic biomarkers are highly needed. OBJECTIVE: To assess the prognostic valu...
Autores principales: | Petržalka, Marko, Meluzínová, Eva, Libertínová, Jana, Mojžišová, Hana, Hanzalová, Jitka, Ročková, Petra, Elišák, Martin, Kmetonyová, Silvia, Šanda, Jan, Sobek, Ondřej, Marusič, Petr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236235/ https://www.ncbi.nlm.nih.gov/pubmed/35759479 http://dx.doi.org/10.1371/journal.pone.0270607 |
Ejemplares similares
-
Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
por: Liba, Zuzana, et al.
Publicado: (2016) -
MxA mRNA decrease preceding NAb detection in IFNβ‐treated MS patients
por: Libertinova, Jana, et al.
Publicado: (2017) -
Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2
por: He, Chuan Hua, et al.
Publicado: (2013) -
IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses
por: Lee, Chang-Min, et al.
Publicado: (2016) -
Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ
por: Libertinova, Jana, et al.
Publicado: (2017)